Press Releases

Noramco and SPI Pharma sign letter of intent to develop formulation solution packages

Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients, and SPI Pharma, a global leader in the manufacture and supply of functional excipient platforms and drug development services, signed a letter of intent to develop and license formulation packages…

Noramco welcomes enquiries from the news media.

Whether you are looking for basic company information or have a follow up question regarding a recent press release, we are here to help. During regular business hours (8:00AM-5:30PM EST, M-F) members of the media should call our corporate headquarters.

A major producer of specialty APIs for the pharmaceutical industry, Noramco is qualified to provide commentary in a number of topic areas, including API research and development, reference standards, and custom synthesis. For assistance, contact us.